Table 1.
Final multivariate overall survival model for 110 patients receiving gemcitabine-based chemoradiation for potentially resectable pancreatic cancer
Final multivariate overall survival model for 110 patients receiving gemcitabine-based chemoradiation for potentially resectable pancreatic cancer